Szczepańska, E.; Słoma-Krześlak, M.; Białek-Dratwa, A.; Dudzik, I.; Kowalski, O.
Adipose Dysfunction Indices as a Key to Cardiometabolic Risk Assessment—A Population-Based Study of Post-Myocardial Infarction Patients. Metabolites 2024, 14, 299.
https://doi.org/10.3390/metabo14060299
AMA Style
Szczepańska E, Słoma-Krześlak M, Białek-Dratwa A, Dudzik I, Kowalski O.
Adipose Dysfunction Indices as a Key to Cardiometabolic Risk Assessment—A Population-Based Study of Post-Myocardial Infarction Patients. Metabolites. 2024; 14(6):299.
https://doi.org/10.3390/metabo14060299
Chicago/Turabian Style
Szczepańska, Elżbieta, Małgorzata Słoma-Krześlak, Agnieszka Białek-Dratwa, Izabela Dudzik, and Oskar Kowalski.
2024. "Adipose Dysfunction Indices as a Key to Cardiometabolic Risk Assessment—A Population-Based Study of Post-Myocardial Infarction Patients" Metabolites 14, no. 6: 299.
https://doi.org/10.3390/metabo14060299
APA Style
Szczepańska, E., Słoma-Krześlak, M., Białek-Dratwa, A., Dudzik, I., & Kowalski, O.
(2024). Adipose Dysfunction Indices as a Key to Cardiometabolic Risk Assessment—A Population-Based Study of Post-Myocardial Infarction Patients. Metabolites, 14(6), 299.
https://doi.org/10.3390/metabo14060299